Skip to main content
Premium Trial:

Request an Annual Quote

Genome Pharmaceuticals Sets Up Research Team


MUNICH--Genome Pharma ceuticals, a genomics-based drug discovery company here, announced the appointment of Zoltan Nagy as vice-president of immunology. Nagy previously held positions as a scientific member of the Basel Institute of Immunology, deputy director of the Max Planck Institute for Biology, project leader in preclinical research at Novartis, and most recently as department head of immunology at Hoffmann-La Roche.

Genome Pharmaceuticals said it has an integrated platform of automated and proprietary high-throughput functional genomics technologies comprising in-depth gene structure and expression analyses, protein-protein interaction mapping, and advanced bioinformatics tools designed to streamline the process of target identification and validation. The company said its short-term goal is to assist major pharmaceutical companies in the process of drug discovery and development. The company said it also plans further to expand its technology base to become an integrated drug discovery company.

Filed under

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.